Skip to main content
. 2019 May 9;6(2):ENEURO.0031-19.2019. doi: 10.1523/ENEURO.0031-19.2019

Figure 4.

Figure 4.

GLP-1 (9-36) treatment rescues hippocampal synaptic plasticity impairments in Ts65Dn mice. A, Acute hippocampal slices from WT+ Saline (n = 9), Ts65Dn + Saline (n = 10), WT+ GLP-1 (9-36) (n = 10), and Ts65Dn + GLP-1 (9-36) (n = 9) mice were stimulated with HFS to induce LTP at the CA3-CA1 synapse. Arrow indicates HFS. Two-way repeated-measures ANOVA revealed significant group (p < 0.05), time (p < 0.05), and group × time (p < 0.001) effects. At 90 min post-HFS, Tukey’s post hoc tests revealed Ts65Dn + Saline had significantly impaired LTP compared with GLP-1 (9-36)-treated Ts65Dn mice (p < 0.05) and saline- and GLP-1 (9-36)-treated WT mice (p < 0.001, p < 0.05). B, Measurement of fEPSP slope at 30, 60, and 90 min after HFS (*p < 0.05, **p < 0.01). C, Representative fEPSP traces at baseline and 90 min post-HFS. D, I/O curves were established by plotting fEPSP amplitudes against fiber volley amplitudes at increasing stimulus intensities in hippocampal slices from WT+ Saline (n = 9), Ts65Dn + Saline (n = 10), WT+ GLP-1 (9-36) (n = 9), and Ts65Dn + GLP-1 (9-36) (n = 9) mice. One-way ANOVA revealed no significant differences between groups at any time point. E, PPF in WT+ Saline (n = 9), Ts65Dn + Saline (n = 10), WT+ GLP-1 (9-36) (n = 9), and Ts65Dn + GLP-1 (9-36) (n = 9) mice. One-way ANOVA revealed no significant differences between groups at any time point.